BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Jun 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-04-30

Reporting Person: Davis George Eric (EVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-30	Common Stock	A	309	$68.782	Acquired	88364	Direct
2018-06-04	Common Stock	F	1414	$92.070	Disposed	86950	Direct

Footnotes

F1: Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.

F2: Amount of securities beneficially owned has been adjusted from the reporting person's prior report to: a) add 79 shares reported as acquired in the Form 4 Amendment filed with the S.E.C. on 4/26/2018; and b) subtract 13 shares reported as disposed of in the Form 4 Amendment filed with the S.E.C. on 4/27/2018.